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BACKGROUND: Blood donors have an increased risk of low hemoglobin (Hb) levels due to iron deficiency. Therefore, knowledge of genetic variants associated with low Hb could facilitate individualized donation intervals. We have previously reported three specific singlenucleotide polymorphisms that were associated with ferritin levels in blood donors. In this study, we investigated the effect of these single-nucleotide polymorphisms on Hb levels in 15,567 Danish blood donors.
STUDY DESIGN AND METHODS:
We studied 15, 567 participants in the Danish Blood Donor Study. The examined genes and single-nucleotide polymorphisms were 1) TMPRSS6, involved in regulation of hepcidin: rs855791; 2) HFE, associated with hemochromatosis: rs1800562 and rs1799945; 3) BTBD9, associated with restless leg syndrome: rs9357271; and 4) TF, encoding transferrin: rs2280673 and rs1830084. Associations with Hb levels and risk of Hb deferral were assessed in multivariable linear and logistic regression models.
RESULTS:
The HFE,rs1800562 G-allele and the HFE rs1799945 C-allele were associated with lower Hb levels in men and women, and with an increased risk of Hb below 7.8 mmol/L (12.5 g/dL) in women. Only the rs1799945 C-allele increased the risk of Hb below 8.4 mmol/L (13.5 g/dL) in men. In TMPRSS6, the rs855791 T-allele was associated with lower Hb levels in both men and women, and with an increased risk of low Hb among women.
CONCLUSION:
With this study we demonstrate that HFE and TMPRSS6 are associated with Hb levels and risk of Hb below the limit of deferral. Thus, genetic testing may be useful in a future assay for personalized donation intervals.
O ne whole blood donation entails the loss of 200 to 250 mg of iron through hemoglobin (Hb) in erythrocytes. Thus, frequent blood donors have a high risk of both iron deficiency and anemia. In a previous study from the Danish Blood Donor Study (DBDS), we observed iron deficiency (defined as a ferritin level <15 ng/mL) in 9% of high-frequency male blood donors, and in 39% among high-frequency female donors below the age of 50 years. 1 Similar findings have been reported in other blood donor populations. 2 Another study from the DBDS showed that a low ferritin level is the strongest predictor for Hb below deferral limits in blood donors. 3 Hb below deferral limits is the most frequent cause of blood donor deferral. 3 Thus, to maintain the supply of blood products vital to modern health care, knowledge that can be used to prevent iron deficiency anemia is highly needed.
We have previously described a number of genetic markers relevant to iron homeostasis that were associated with ferritin levels in blood donors. 4, 5 Specifically, alleles within HFE, TMPRSS6, BTBD9, and TF were all found to be statistically significantly associated with ferritin levels among male blood donors and, in the case of HFE, also among female blood donors. However, while the three mentioned single-nucleotide polymorphisms (SNPs) were associated with the ferritin level of blood donors, the SNPs were not consistently associated with the risk of iron deficiency. Only the HFE rs1799945 C-allele was significantly associated with iron deficiency in women. While useful to gauge tissue iron stores, ferritin measurements are rarely used routinely for donor eligibility assessment in connection with blood donation. To this end, blood banks typically resort to Hb measurements instead. Because genetic factors have previously been shown to be associated with Hb levels, [6] [7] [8] we hypothesized that the genetic variants previously found to be associated with ferritin levels would also be associated with Hb and with the risk of Hb levels below deferral limits.
MATERIALS AND METHODS

Donor population
A total of 15,567 participants from the DBDS, an ongoing multicenter, epidemiologic cohort and biobank, were included. The study population has previously been described in detail elsewhere. 1, 9 Briefly, individuals who had donated blood two or more times were invited to participate in the study. Upon inclusion, participants fill out a comprehensive health-related questionnaire including items on weight, height, intake of vitamin pills, and receipt of iron pills at the previous blood donation. Information on participants' donation history and on Hb levels measured in connection with the donation is obtained through the Scandinavian Donations and Transfusions Database. 10 
Hemoglobin and SNP analyses
Hb levels considered in the present analyses were measured on a hematology analyzer (Sysmex KX21N, Sysmex) after the completion of the donation in venous blood samples taken either before or after the donation depending on regional procedures. Consequently, no donors were excluded from the present analyses due to failed Hb screens. Based on a literature search (described elsewhere 4 ) and on findings from our previous study, we investigated SNPs in the following genes: 1) TMPRSS6: rs855791, 2) BTBD9: rs9357271, 3) TF: rs2280673 and rs11830084, and 4) HFE: rs1800562 and rs1799945. DNA was extracted and analyzed by LGC Genomics Extraction and Genotyping Service.
Ferritin level
The ferritin level was considered a covariate in the association between the identified SNPs and Hb level. Ferritin levels in the participants were measured in thawed ethylenediaminetetraacetic acid-anticoagulated plasma samples from all study participants using a commercially available assay on an automated system (Ortho Vitros 5600, Ortho Clinical Diagnostics), as previously described. 4 
Statistical analyses
Tests for Hardy-Weinberg equilibrium were performed for each SNP using computer software (AssoTest version 0.4, Department of Biostatistics, University of Copenhagen). All other statistical analyses were performed using statistical software (Stata/IC 11.2 for Macintosh, StataCorp). All analyses were stratified according to sex. T tests were used to test differences between men and women for normally distributed data (age, body mass index, and Hb levels), MannWhitney U-tests were applied for non-normally distributed data (number of donations for the past 3 years), and, finally, chi-squared tests were used to test difference between men and women when examining dichotomous variables (smoking status, intake of iron pills or vitamins). Associations between the genetic polymorphisms and Hb levels were assessed using multivariable linear regression analyses, and results were presented as regression coefficients with p values and 95% confidence intervals (CIs). Multivariable logistic regression analyses were used to assess if any of the genetic polymorphisms predicted the risk of deferral Hb levels defined as below 7.8 mmol/L (12.5 g/dL) and 8.4 mmol/L (13.5 g/dL) in female and male donors, respectively. Results from the logistic regression models were presented as odds ratios (ORs) with p values and 95% CIs.
All regression analyses were adjusted for body mass index, smoking status, age, time since previous donation, number of donations in the preceding 3 years, intake of iron pills since last donation, intake of vitamin pills, menopausal status in women, and whether Hb was measured in samples collected before or after donation. Furthermore, we conducted a number of post hoc analyses where ferritin level was also entered into the regression models. This was done to assess the mediating role of ferritin (results not shown).
No correction for repeated analysis was performed. P values below 0.05 were considered statistically significant.
Ethical considerations
Oral and written informed consent was obtained from each participant. The study was approved by the Scientific Ethical Committee of Central Denmark (case no. M-20090237). The biobank and research database were approved by the Danish Data Protection Agency (case no. 2007-58-0015).
RESULTS
The SNPs were genotyped in 17,683 individuals, with a success rate varying from 99.3% to 99.6% for all six SNPs. All allele frequencies were in Hardy-Weinberg equilibrium in the total population (p > 0.05). In total, 2116 individuals with missing items on the DBDS questionnaire and/or with extreme anthropometric data (to avoid bias of the results from, e.g., an unrealistic weight of 720 kg) and/or missing ferritin measurement were excluded from the study. Thus, complete relevant data were available for 8333 men and 7234 women. The genotype and minor allele frequencies of the SNPs in the study participants are presented in Table 1 .
Distribution of all possible confounders differed between men and women (Table 2; all p values <0.01). There was a mean difference in Hb levels between donation sites collecting samples for Hb measurements before and after donation of 0.4 mmol/L (95% CI, 0.1-1.5 mmol/L) for men and 0.4 mmol/L (95% CI, 0.2-1.5 mmol/L) for women ( Table 2) .
Prediction of hemoglobin levels
The individual effects of each SNP on Hb levels were examined using multivariable linear regression analyses. These analyses showed an additive negative association between Hb levels and the HFE rs1799945 C-allele and the rs1800562 G-allele and the TMPRSS6 rs855791 T-allele in both men and women (Table 3) . No statistically significant associations with Hb levels were observed for the other SNPs (Table 3) . Figure 1 presents the distributions of Hb levels among male and female blood donors according to investigated genotypes. Each base change from HFE rs1800562 AA to GA and from GA to GG correlated to a decrease in Hb of Fig. 1 ). When comparing Hb levels between individuals being homozygotes in all three significant SNPs mentioned above (HFE rs1800562 GG and rs1799945 CC; TMPRSS6 rs855791 TT), and all other genotypes, we found that the effects were in the same range as effects from HFE rs1800562 (data not shown).
Prediction of hemoglobin levels below deferral limits
Multivariable logistic regression models were used to investigate if any of the SNPs increased the risk of Hb levels below deferral limits ( Table 4 ). The OR for Hb below deferral limits was 1.39 (95% CI, 1.10-1.76) and 1.20 (95% CI, 1.02-1.41) for male and female donors, respectively, for each additional copy of the C-allele in the HFE rs1799945 with an additive genetic model. In HFE rs1800562, each additional G-allele was associated with an increased risk of Hb below deferral limits with an OR of 1.52 (95% CI, 1.07-2.17) among male donors, whereas no statistically significant association was observed among female donors. Conversely, only among female donors was the T-allele TMPRSS6 associated with the risk of Hb below deferral limits (OR = 1.21; 95% CI, 1.08-1.35). The risk of Hb below deferral limits in individuals being homozygotes in all three significant SNPs mentioned above (HFE rs1800562 GG and rs1799945 CC; TMPRSS6 rs855791 TT), compared to all others were in the same range as for individual SNPs (data not shown).
Post hoc multivariable logistic regression analyses adjusted for ferritin level showed similar results (not shown), and in mediation analyses we found that 5% and 7% of the effect of rs1799945 on Hb levels was mediated through the effect of rs1799945 on ferritin levels in men and women, respectively. Further, 19% of the effect of rs1800562 on Hb levels was mediated through the effect of rs1800562 on ferritin levels in both sexes. However, no mediating effect through ferritin levels was observed when examining TMPRSS6 rs855791.
DISCUSSION
In an analysis of 17,683 Danish blood donors, the HFE rs1800562 G-allele and the rs1799945 C-allele and the TMPRSS6 rs855791 T-allele were each negatively associated with Hb levels among men and women. When examined in relation to risk of subdeferral-limit Hb levels, findings were less homogeneous, as associations were observed in both sexes only for the C-allele of rs1799945, while the rs1800562 G-allele and the rs1800562 T-allele were associated with risk of Hb below deferral limits only in male and female donors, respectively. It has previously been estimated that the effort to prevent iron deficiency through Hb-level monitoring annually leads to temporary deferral of 5% of the blood donor population. 11 Unfortunately, such temporary deferrals often lead to loss of the donor from the donor population. 12 Therefore, knowledge allowing the prevention of donation-related anemia and subsequent deferral could prove valuable to donor retention strategies. Mitigating strategies could entail personalized donation schemes with, for example, longer time intervals between donations, intensified iron replacement, or dietary advice; and, further, genetic markers associated with Hb levels and/or iron stores may likewise be useful in the creation of personalized donor management. Information on genetic factors contributing to Hb below deferral limits is also valuable for guided iron supplementation to blood donors because it is not advisable to administer iron pills unguided to blood donors. Intake of iron supplements may harm donors with hemochromatosis or mask the presence of an underlying disease, such as colorectal cancer. 13 Furthermore, knowledge of hereditary factors predisposing to Hb below deferral limits could be generalized to improve care and advice given to other groups at risk for Hb below deferral limits, such as women of childbearing age. Several studies have found that SNPs in TMPRSS6 are associated with iron levels. Our analyses showed that the Hb level decreased additively for each T-allele in TMPRSS6 among both men and women, and that the same allele was associated with an increased risk of Hb below deferral limits in women. This is consistent with a finding in a genome-wide association study of 16,001 individuals of both European and Asian origin, 6 which emphasizes that this gene has an important role in regulating Hb. As described in the introduction, the TMPRSS6 plays a role in regulating hepcidin synthesis. 14 An overexpression of TMPRSS6 may result in iron overload because of blockage of different pathways for upregulation of hepcidin, 8, 15 and it has been suggested that mutational inactivation of the TMPRSS6 reduces the level of serum iron or Hb. 6, 16, 17 Our findings are consistent with previous studies reporting that the HFE rs1800562 A-allele, which is also known as C282Y, is the most common genetic variant for causing iron overload. 18 Further, the rs1799945 G-allele, also known as H63D, is overrepresented in patients with hemochromatosis who are heterozygous for rs1800562. 4 Previously, we reported that inclusion of the HFE variants could be useful in constructing a "super donor" identification assay, 4 which was originally suggested by Kiss.
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The rationale was that we found the HFE rs1800562 A-allele and the GG genotype in HFE rs1799945 to be associated with increased ferritin levels, 4 which has been confirmed in previous genome-wide association study. 17, 20 The present findings both support and add to this suggestion.
A potential limitation in the current study is that the observed effects on Hb levels were small. Thus, fluctuations between measurements in different donor centers would have a relatively high impact and potentially bias the results. However, as opposed to many other blood centers where Hb is measured in the donation facility, our tests were performed in two well-controlled laboratory settings applying to high standards. Furthermore, we did not find differences in the distribution of SNPs between the two regions. The technical variation in the measurement of Hb most likely added noise and not bias to the subsequent statistical analysis of the effects of the SNPs. The main strength of this study is the size of the study population and the fact that it was conducted in a study cohort where medications do not bias the results. It should be noted, however, that some donors were offered iron supplements in the blood banks. However, entering ferritin into the statistical models did not change the associations, which means that these genetic variants have effect on the iron metabolism beyond what is caused by the effect on the estimated iron stores.
In conclusion, with this study we demonstrated that variants of HFE and TMPRSS6 were associated with Hb levels in men and women. Moreover, we found that the HFE rs1800562 G-allele and the HFE rs1799945 C-allele were associated with Hb below deferral limits in men, whereas only the rs1799945 C-allele increased the risk in * Adjusted for body mass index, smoking status, age, time since last donation, number of donations within the past 3 years, intake of iron tablets and vitamin pills, menopausal status in women, and whether the Hb level was measured before or after blood donation. Deferral due to low Hb occurs when Hb level < 7.8 mmol/L for women and Hb < 8.4 mmol/L for men. CI = confidence interval; Hb = hemoglobin; OR = odds ratio; SNPs = single-nucleotide polymorphisms.
women. Thus, the effect of these genes on the risk of Hb below deferral limits was not equal in men and women. Furthermore, the T-allele of rs855791 in TMPRSS6 increased the risk of Hb below deferral limits in women. This knowledge may prove useful in preventing donor deferral through implementation of personalized donation intervals based on genetic testing of blood donors. It should be noted, however, that although statistically significant, the differences in Hb levels between genotypes were small. Therefore, the results of this are not applicable for decision making regarding practical donation management. Further research to evaluate the impact of genetic factors influencing Hb levels is therefore warranted.
